Methodology

All entries for: GEn1E Lifesciences Inc.

April 28, 2026

GEn1E Lifesciences Inc.

Orphan Drug Designation

treatment of Duchenne muscular dystrophy

Disease Area: Rare Diseases
Source
Scroll to Top